Title | Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies [electronic resource] / edited by G. Bennett Humphrey, H. Schraffordt Koops, W. M. Molenaar, A. Postma |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 1993 |
Connect to | http://dx.doi.org/10.1007/978-1-4615-3518-8 |
Descript | XXIII, 407 p. online resource |
I. Selected Topics: A. Introduction -- 1. Osteosarcoma at the end of the 20th century/Tumor biology -- B. General -- 2. Retroviruses and oncogenes associated with osteosarcomas -- 3. In vivo 31-phosphorus nuclear magnetic resonanc spectroscpy of osteosarcoma -- 4. Perioperative blood transfusions and survival in osteosarcoma -- 5. Adjuvant interferon treatment in human osteosarcoma -- 6. Difference of osteosarcoma between Southwest England and the Kanto area of Japan in relation to age, sex and localization -- 7. Psychological effects of amputation in osteosarcoma -- 8. Late effects of therapy in survivors of childhood and adolescent osteosarcoma -- C. Pharmacology -- 9. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma -- 10. Doxorubicin: Role in the treatment of osteosarcoma -- 11. Pediatric osteosarcoma: Treatment of the primary tumor with intraarterial cis-Diamminedichloroplatinum-II (CDP) Advantages, disadvantages and controversial issues -- 12. Intraarterial chemotherapy for osteosarcoma: Does the result really justify the effort -- 13. Thermal chemosensitization of DDP in normal and resistant cells -- 14. Liposome-encapsulated muramyl tripeptide: A new biologic response modifier for the treatment of osteosarcoma -- D. Pathology -- 15. Pathological diagnosis of osteosarcoma: The validity of the subclassification and some new diagnostic approaches using immunohistochemistry -- 16. Histologic subclassification of osteosarcoma: Differential diagnostic problems and immunohistochemical aspects -- 17. Small cell osteosarcoma -- 18. Current status of DNA cytometry in osteosarcoma -- 19. Osteosarcomatosis and metastatic osteosarcoma -- E. Radiotherapy -- 20. Experience of the EORTC Radiotherapy/Chemotherapy Group and in osteosarcoma trials -- 21. Intraoperative radiation therapy for osteosarcoma -- F. Surgery -- 22. Surgery of osteosarcoma of the extremities: Indications and Complications in the recent experience at the Instituto Ortopedico Rizzoli -- 23. Limb sparing for skeletally immature patients with osteosarcoma: The expandable Prosthesis -- 24. A modular endoprosthetic system, non-invasively extendable, for young patients with osteosarcoma -- 25. A critique of techniques for reconstruction after internal hemipelvectomy for osteosarcoma -- 26. Diffusion of methotrexate from surgical acrylic cement -- 27. Hyperthermic isolated prefusion using Cisplatin for the treatment of the extremities -- 28. Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics and toxicity of Cisplatin -- 29. Effect of isolated limb prefusion with Cisplatin (CDDP) on canine osteosarcoma -- 30. Salvage surgery for childhood osteosarcoma -- II. CO-Operative Groups And Institutional Reports: A. Co-operative Groups -- 31. The Multiinstitutional Osteosarcoma Study: An update. -- 32. Treatment of osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group (COSS) -- 33. The European Osteosarcoma Intergroup (E.O.I.) Studies 1980โ1991 -- 34. The Childrenโs Cancer Study Group (CCSG) Studies -- 35. An update of Scandinavian studies of osteosarcoma -- B. Institutional Reports -- 36. Neoadjuvant chemotherapy for non metastatic osteosarcoma of the extremities: The recent experience at the Rizzoli Institute -- 37. Osteosarcoma of the extremities: Chemotherapy experience at Memorial Sloan-Kettering -- 38. Osteosarcoma studies at St. Jude Childrenโs Research Hospital from 1968 through 1990 -- 39. A monocentric therapy study: An approach to optimize the results of the treatment of osteosarcoma by protocols based upon HD MTX, associated with systematic conservative surgery -- 40. The Mayo Clinic studies -- 41. Neoadjuvant Chemotherapy for Patients with osteosarcoma: University of Flordia studies -- 42. Chemotherapy in osteogenic sarcoma: The experience of the Pediatric Department of the Gustave Roussy Institute -- 43. Results of therapy in osteosarcoma: Experience in children hospitals in Buenos Aires -- 44. Osteosarcoma: Experience with the Rosen T10 protocol at RCH, Melbourne -- 45. Osteosarcoma of the limb: An institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery -- 46. Osteosarcoma: Experience of the Tata Memorial Hospital, Bombay, India -- 47. Update of osteosarcoma in Ramathibodi, Thailand -- III. Summaries, Critiques and Editorial Comments -- 48. Commentary on pathology -- 49. Is there a rational role for radiotherapy in the treatment of osteosarcoma? A radiotherapistโs point of view -- 50. Commentary on the use of presurgical chemotherapy -- 51. Critique on the use of presurgical chemotherapy